A 42-year-old woman undergoes surgery for cholesteatoma. Intraoperatively, the surgeon suspects residual disease despite careful dissection. Which investigation is most appropriate to detect residual cholesteatoma in the immediate postoperative period?

Explanation

## Detection of Residual Cholesteatoma: Postoperative Imaging **Key Point:** Diffusion-weighted MRI (DWI) is the most sensitive investigation for detecting residual cholesteatoma in the postoperative period, with sensitivity and specificity both exceeding 95%. ### Why MRI-DWI is Superior for Postoperative Detection 1. **High Sensitivity & Specificity**: DWI detects restricted diffusion from cholesteatoma epithelium, which appears hyperintense on b-value images. 2. **No Ionizing Radiation**: Safe for postoperative follow-up, especially important in pediatric patients. 3. **Differentiates from Granulation Tissue**: Unlike HRCT, DWI can distinguish cholesteatoma from postoperative inflammation and granulation tissue. 4. **Timing**: Performed at 4–6 weeks postoperatively to allow resolution of postoperative edema and blood products that may mimic cholesteatoma on early imaging. ### Postoperative Imaging Strategy | Timing | Investigation | Purpose | Rationale | |---|---|---|---| | **Immediate (intraop)** | Intraoperative endoscopy/microscopy | Real-time visualization | Surgeon's direct assessment | | **4–6 weeks postop** | **MRI-DWI** | Detect residual disease | Edema resolved; high sensitivity for cholesteatoma | | **Later (3–6 months)** | HRCT if residual confirmed | Assess extent for revision surgery | Bony anatomy for surgical planning | **Clinical Pearl:** The **delayed postoperative MRI-DWI** (4–6 weeks) is now standard of care in many centers to screen for residual disease, reducing the need for planned second-look surgery in canal wall-down (CWD) procedures. **High-Yield:** **DWI sequences** show **hyperintensity** in cholesteatoma because of restricted water diffusion in the keratinous debris and epithelial matrix — this is pathognomonic and highly specific. **Mnemonic: RESIDUAL DETECTION — DWI** - **D**iffusion-weighted imaging - **W**ater restriction in cholesteatoma - **I**maging at 4–6 weeks (postoperative edema resolved) **Warning:** ~~HRCT at 2 weeks~~ will show postoperative changes, edema, and blood products that obscure residual disease. ~~Repeat otoscopy~~ cannot visualize residual disease in the epitympanic recess or sinus tympani. ~~Electrocochleography~~ assesses cochlear function, not structural disease.